Volinanserin

DB16351InvestigationalSmall molecule

Volinanserin is under investigation in clinical trial NCT00464243 (Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study).

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2A
Curator reviewed
Formula / weight: C₂₂H₂₈FNO₃ · 373.468 g/mol (avg)
Code names: M-100907 · MDL-100.907

Resolves to

Compound

UNIIEW71EE171JCAS139290-65-6ChEMBLCHEMBL74355

Structure

InChIKeyHXTGXYRHXAGCFP-OAQYLSRUSA-NSMILESCOC1=C(OC)C(=CC=C1)[C@H](O)C1CCN(CCC2=CC=C(F)C=C2)CC1

Targets

P28223HTR2AP28335HTR2CQ12809KCNH2

What you can answer from here — as of May 27, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Volinanserin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account